These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23517603)

  • 1. Stress hormones promote growth of B16-F10 melanoma metastases: an interleukin 6- and glutathione-dependent mechanism.
    Valles SL; Benlloch M; Rodriguez ML; Mena S; Pellicer JA; Asensi M; Obrador E; Estrela JM
    J Transl Med; 2013 Mar; 11():72. PubMed ID: 23517603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intertissue flow of glutathione (GSH) as a tumor growth-promoting mechanism: interleukin 6 induces GSH release from hepatocytes in metastatic B16 melanoma-bearing mice.
    Obrador E; Benlloch M; Pellicer JA; Asensi M; Estrela JM
    J Biol Chem; 2011 May; 286(18):15716-27. PubMed ID: 21393247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid receptor knockdown decreases the antioxidant protection of B16 melanoma cells: an endocrine system-related mechanism that compromises metastatic cell resistance to vascular endothelium-induced tumor cytotoxicity.
    Obrador E; Valles SL; Benlloch M; Sirerol JA; Pellicer JA; Alcácer J; Coronado JA; Estrela JM
    PLoS One; 2014; 9(5):e96466. PubMed ID: 24802641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceleration of glutathione efflux and inhibition of gamma-glutamyltranspeptidase sensitize metastatic B16 melanoma cells to endothelium-induced cytotoxicity.
    Benlloch M; Ortega A; Ferrer P; Segarra R; Obrador E; Asensi M; Carretero J; Estrela JM
    J Biol Chem; 2005 Feb; 280(8):6950-9. PubMed ID: 15561710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of glutathione and Bcl-2 synthesis in mouse B16 melanoma cells avoids their survival during interaction with the vascular endothelium.
    Ortega A; Ferrer P; Carretero J; Obrador E; Asensi M; Pellicer JA; Estrela JM
    J Biol Chem; 2003 Oct; 278(41):39591-9. PubMed ID: 12881529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of thymosin beta4 in tumor metastasis and angiogenesis.
    Cha HJ; Jeong MJ; Kleinman HK
    J Natl Cancer Inst; 2003 Nov; 95(22):1674-80. PubMed ID: 14625258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas.
    Seguin F; Carvalho MA; Bastos DC; Agostini M; Zecchin KG; Alvarez-Flores MP; Chudzinski-Tavassi AM; Coletta RD; Graner E
    Br J Cancer; 2012 Sep; 107(6):977-87. PubMed ID: 22892389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. gamma-Glutamyl transpeptidase overexpression increases metastatic growth of B16 melanoma cells in the mouse liver.
    Obrador E; Carretero J; Ortega A; Medina I; Rodilla V; Pellicer JA; Estrela JM
    Hepatology; 2002 Jan; 35(1):74-81. PubMed ID: 11786961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-2 increases intracellular glutathione levels and reverses the growth inhibiting effects of cyclophosphamide on B16 melanoma cells.
    Palomares T; Alonso-Varona A; Alvarez A; Castro B; Calle Y; Bilbao P
    Clin Exp Metastasis; 1997 May; 15(3):329-37. PubMed ID: 9174132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases.
    Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L
    Cancer Res; 1995 Nov; 55(21):4941-9. PubMed ID: 7585534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hinokitiol, a tropolone derivative, inhibits mouse melanoma (B16-F10) cell migration and in vivo tumor formation.
    Huang CH; Lu SH; Chang CC; Thomas PA; Jayakumar T; Sheu JR
    Eur J Pharmacol; 2015 Jan; 746():148-57. PubMed ID: 25449038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-2 and glutathione depletion sensitizes B16 melanoma to combination therapy and eliminates metastatic disease.
    Mena S; Benlloch M; Ortega A; Carretero J; Obrador E; Asensi M; Petschen I; Brown BD; Estrela JM
    Clin Cancer Res; 2007 May; 13(9):2658-66. PubMed ID: 17473197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1.
    Khokha R
    J Natl Cancer Inst; 1994 Feb; 86(4):299-304. PubMed ID: 8158685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma.
    Lucas ML; Heller L; Coppola D; Heller R
    Mol Ther; 2002 Jun; 5(6):668-75. PubMed ID: 12027550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of vimentin and 14-3-3 zeta/delta in the inhibitory effects of heparin on PC-3M cell proliferation and B16-F10-luc-G5 cells metastasis.
    Pan Y; Zhong LJ; Zhou H; Wang X; Chen K; Yang HP; Xiaokaiti Y; Maimaiti A; Jiang L; Li XJ
    Acta Pharmacol Sin; 2012 Jun; 33(6):798-808. PubMed ID: 22669117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective adoptive transfer of haploidentical tumor-specific T cells in B16-melanoma bearing mice.
    Cui NP; Xie SJ; Han JS; Ma ZF; Chen BP; Cai JH
    Chin Med J (Engl); 2012 Mar; 125(5):794-800. PubMed ID: 22490577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N-acetylcysteine.
    Albini A; D'Agostini F; Giunciuglio D; Paglieri I; Balansky R; De Flora S
    Int J Cancer; 1995 Mar; 61(1):121-9. PubMed ID: 7705924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-33 pretreatment promotes metastatic growth of murine melanoma by reducing the cytotoxic capacity of CD8
    Jevtovic A; Pantic J; Jovanovic I; Milovanovic M; Stanojevic I; Vojvodic D; Arsenijevic N; Lukic ML; Radosavljevic GD
    Cancer Immunol Immunother; 2020 Aug; 69(8):1461-1475. PubMed ID: 32285171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth and metastasis of B16-F10 melanoma cells is not critically dependent on host CD73 expression in mice.
    Burghoff S; Gong X; Viethen C; Jacoby C; Flögel U; Bongardt S; Schorr A; Hippe A; Homey B; Schrader J
    BMC Cancer; 2014 Dec; 14():898. PubMed ID: 25465225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous administration of bone marrow-derived multipotent mesenchymal stromal cells enhances the recruitment of CD11b(+) myeloid cells to the lungs and facilitates B16-F10 melanoma colonization.
    Souza LE; Almeida DC; Yaochite JN; Covas DT; Fontes AM
    Exp Cell Res; 2016 Jul; 345(2):141-9. PubMed ID: 26027946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.